These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8684533)

  • 1. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
    Kobayashi Y; Hiki Y; Kokubo T; Horii A; Tateno S
    Nephron; 1996; 72(2):237-42. PubMed ID: 8684533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
    Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Tateno S
    Nephron; 1989; 53(3):250-6. PubMed ID: 2797345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
    Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
    Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
    Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
    Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyana M; Tateno S
    Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center.
    Koike M; Takei T; Uchida K; Honda K; Moriyama T; Horita S; Ogawa T; Yoshida T; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2008 Aug; 12(4):250-255. PubMed ID: 18286351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP; van den Brand JA; Berger SP; Wetzels JF
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of corticosteroids on renal function in progressive IgA nephropathy--long-term follow-up study.
    Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyama M; Tateno S
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1135-42. PubMed ID: 3216556
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
    Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
    J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
    Ballardie FW; Roberts ISD
    J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
    Katafuchi R; Ikeda K; Mizumasa T; Tanaka H; Ando T; Yanase T; Masutani K; Kubo M; Fujimi S
    Am J Kidney Dis; 2003 May; 41(5):972-83. PubMed ID: 12722031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.